Ursodeoxycholic acid(UDCA) - Moligand™, ≥99% , Bile acid receptor FXR agonist, CAS No.128-13-2, Bile acid receptor FXR agonist

CAS: 128-13-2 Cat. No.: U110695 Molecular Weight: 392.57 Beilstein Registry Number: 3219888 EC Number: 204-879-3
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%
Synonyms
UDCS | 4-10-00-01604 (Beilstein Handbook Reference) | Lyeton | MFCD00003680 | URSODIOL [USP-RS] | UNII-724L30Y2QR | 3alpha,7beta-Dihydroxy-5beta-cholanic acid | Acido ursodeoxicolico [INN-Spanish] | URSODIOL [INCI] | Ursodiol [USAN] | 17-beta-(1-Methyl-3-
Storage
Room temperature,Argon charged,Desiccated,Cool
Shipped In
Normal
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
1g
U110695-1g
1
$9.90
5g
U110695-5g
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$19.90
25g
U110695-25g
4
$43.90
100g
U110695-100g
3
$152.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™, ≥99% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Room temperature,Argon charged,Desiccated,Cool Ships Normal Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 65 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Ursodeoxycholic acid is a bile acid with significant colon chemopreventive activity.
Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.

Specifications

Synonyms
UDCS | 4-10-00-01604 (Beilstein Handbook Reference) | Lyeton | MFCD00003680 | URSODIOL [USP-RS] | UNII-724L30Y2QR | 3alpha, 7beta-Dihydroxy-5beta-cholanic acid | Acido ursodeoxicolico [INN-Spanish] | URSODIOL [INCI] | Ursodiol [USAN] | 17-beta-(1-Methyl-3-
Specifications & Purity
Moligand™, ≥99%
Storage
Room temperature, Argon charged, Desiccated, Cool
Shipped In
Normal
Grade
Moligand™
Action Type
AGONIST
Mechanism of action
Bile acid receptor FXR agonist
Purity
≥99%
Product Properties
ALogP4.9
Names and Identifiers
Pubchem Sid488183171
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488183171
Canonical SmilesCC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
IUPAC Name(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
InChIKeyRUDATBOHQWOJDD-UZVSRGJWSA-N
INCHI1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1
Isomeric SMILES C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
WGK Germany 2
RTECS FZ2000000
Molecular Weight 392.57
Beilstein 3219888
Reaxy-Rn 2820380
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=2820380&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
SubclassBile acids, alcohols and derivatives
Intermediate Tree Nodes Hydroxy bile acids, alcohols and derivatives
Direct ParentDihydroxy bile acids, alcohols and derivatives
Alternative Parents 7-alpha-hydroxysteroids  3-alpha-hydroxysteroids  Secondary alcohols  Cyclic alcohols and derivatives  Monocarboxylic acids and derivatives  Carboxylic acids  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic homopolycyclic compounds
Substituents Dihydroxy bile acid, alcohol, or derivatives - 3-hydroxysteroid - 7-hydroxysteroid - 7-alpha-hydroxysteroid - 3-alpha-hydroxysteroid - Hydroxysteroid - Cyclic alcohol - Secondary alcohol - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Organic oxide - Alcohol - Organic oxygen compound - Carbonyl group - Hydrocarbon derivative - Organooxygen compound - Aliphatic homopolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. These are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups.
External Descriptors C24 bile acids, alcohols, and derivatives
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
SLC10A1 Tclin Sodium/bile acid cotransporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C2 Tclin Mineralocorticoid receptor (2134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTH1R Tclin Parathyroid hormone receptor (47172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA4 Tclin Neuronal acetylcholine receptor protein alpha-4 subunit (1265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Associated Targets(non-human)
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1a P-glycoprotein 3 (492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M1AAP Zinc aminopeptidase (902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Clostridioides difficile (2968 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc10a1 Bile acid transporter (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr1h4 Bile acid receptor (142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mdr1a Multidrug resistance protein 1a (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slco1a1 Solute carrier organic anion transporter family member 1A1 (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slco1a3 Solute carrier organic anion transporter family member 1A3 (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

17 results found

Lot NumberCertificate TypeDateItem
C2609525Certificate of AnalysisFeb 06, 2026 U110695
C2609526Certificate of AnalysisFeb 06, 2026 U110695
C2210529Certificate of AnalysisDec 10, 2025 U110695
D2515578Certificate of AnalysisApr 07, 2025 U110695
D2515579Certificate of AnalysisApr 07, 2025 U110695
D2515693Certificate of AnalysisApr 07, 2025 U110695
D2515694Certificate of AnalysisApr 07, 2025 U110695
B2303987Certificate of AnalysisFeb 09, 2023 U110695
I2405025Certificate of AnalysisDec 08, 2021 U110695
I2311009Certificate of AnalysisDec 08, 2021 U110695
H2412493Certificate of AnalysisDec 08, 2021 U110695
E2421037Certificate of AnalysisDec 08, 2021 U110695
E2308141Certificate of AnalysisDec 08, 2021 U110695
E2306043Certificate of AnalysisDec 08, 2021 U110695
E2306039Certificate of AnalysisDec 08, 2021 U110695
C2210433Certificate of AnalysisDec 08, 2021 U110695
B2317075Certificate of AnalysisDec 08, 2021 U110695

Show more ⌵

Chemical and Physical Properties
SolubilitySoluble in ethanol (79 mg/ml at 25 °C), alcohol (freely), chloroform (slightly), and DMSO (79 mg/ml at 25 °C). Insoluble in water.
Specific Rotation[α]60.5 ° (C=4, EtOH)
Melt Point(°C)203°C
Molecular Weight392.600 g/mol
XLogP34.900
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass392.293 Da
Monoisotopic Mass392.293 Da
Topological Polar Surface Area77.800 Ų
Heavy Atom Count28
Formal Charge0
Complexity605.000
Isotope Atom Count0
Defined Atom Stereocenter Count10
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Citations of This Product
References
1. Mu-Qiang Wang, Zhi-Neng You, Bing-Yi Yang, Zi-Wei Xia, Qi Chen, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2023)  Machine-Learning-Guided Engineering of an NADH-Dependent 7β-Hydroxysteroid Dehydrogenase for Economic Synthesis of Ursodeoxycholic Acid.  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,      [PMID:38016669] [10.1021/acs.jafc.3c06339]
2. Yang Chang, Yafei Xia, Xiaojun Liu, Putian Yu, Furong Fan, Yangyang Shi, Shixin Yan, Shu Yan.  (2023)  Integrated 16 S rRNA gene sequencing and serum metabolomics approaches to decipher the mechanism of Qingre Lidan decoction in the treatment of cholestatic liver injury.  JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,      [PMID:37390604] [10.1016/j.jpba.2023.115535]
3. Si-xuan Zhou, Xiao-tong Lin, Jie Wang, Hai-xiang Wang, Gui-tang Chen.  (2023)  Novel hydrocortisone magnetic molecularly imprinted polymers: Preparation, characterization, and application.  FOOD CHEMISTRY,      [PMID:37116443] [10.1016/j.foodchem.2023.136196]
4. Bing-Yi Yang, Zhi-Neng You, Jiang-Tao Xue, Jiang Pan, Chun-Xiu Li, Jian-He Xu.  (2023)  Clean enzymatic production of ursodeoxycholic acid enabled by a newly identified NADH-dependent 7β-hydroxysteroid dehydrogenase.  Molecular Catalysis,      [PMID:] [10.1016/j.mcat.2023.112946]
5. Bin Huang, Kai Yang, Charles Amanze, Zhen Yan, Hongbo Zhou, Xueduan Liu, Guanzhou Qiu, Weimin Zeng.  (2022)  Sequence and structure-guided discovery of a novel NADH-dependent 7β-hydroxysteroid dehydrogenase for efficient biosynthesis of ursodeoxycholic acid.  BIOORGANIC CHEMISTRY,      [PMID:36586301] [10.1016/j.bioorg.2022.106340]
6. Yafei Xia, Shixin Yan, Yang Chang, Jiaoyang Yin, Hongyu Li, Shu Yan.  (2022)  Mechanism and Active Components of Qingre Lidan Tablets Alleviate Intrahepatic Cholestasis by Activating the Farnesoid X Receptor.  Evidence-based Complementary and Alternative Medicine,      [PMID:36506808] [10.1155/2022/1589388]
7. Wang Rulin, Yuan Tengteng, Sun Jing, Yang Menghuan, Chen Yunna, Wang Lei, Wang Yanyan, Chen Weidong, Peng Daiyin.  (2022)  Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats.  Frontiers in Pharmacology,      [PMID:36479204] [10.3389/fphar.2022.1064653]
8. Qing Yang, Xubo Wu, Zhiyu Pan, Ruifang Guan, Ping Yang, Ye Liu, Xiaolei Yang, Wandi Du, Jingru Liang, Jiarong Hu, Weimin Cai, Guo Ma.  (2022)  Integration of pharmacodynamics, network pharmacology and metabolomics to elucidate effect and mechanism of Artemisia capillaris Thunb. in the treatment of jaundice.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:36414211] [10.1016/j.jep.2022.115943]
9. Jiating Zheng, Xiaoru Peng, Taifeng Zhu, Shuyao Huang, Chao Chen, Guosheng Chen, Shuqin Liu, Gangfeng Ouyang.  (2022)  Detection of bile acids in small volume human bile samples via an amino metal-organic framework composite based solid-phase microextraction probe.  JOURNAL OF CHROMATOGRAPHY A,      [PMID:36345074] [10.1016/j.chroma.2022.463634]
10. Wei Xu, Yingying Kong, Tuo Zhang, Zhihua Gong, Wenjun Xiao.  (2022)  L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism.  JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE,  103  (3): (1283-1293).  [PMID:36087337] [10.1002/jsfa.12222]
11. Meng Song, Zijun Chen, Ruian Qiu, Tingwei Zhi, Wenmin Xie, Yingya Zhou, Nachuan Luo, Fuqian Chen, Fang Liu, Chuangpeng Shen, Sheng Lin, Fengxue Zhang, Yong Gao, Changhui Liu.  (2022)  Inhibition of NLRP3-mediated crosstalk between hepatocytes and liver macrophages by geniposidic acid alleviates cholestatic liver inflammatory injury.  Redox Biology,      [PMID:35868156] [10.1016/j.redox.2022.102404]
12. Ma Wen, Yang Bingxin, Li Jun, Liu Mingxia, Li Xianjiang, Liu Huwei.  (2022)  Maltose-functional metal–organic framework assisted laser desorption/ionization mass spectrometry for small biomolecule determination.  MICROCHIMICA ACTA,  189  (7): (1-8).  [PMID:35689150] [10.1007/s00604-022-05338-x]
13. Xiaoxu Cheng, Zifeng Pi, Zhong Zheng, Shu Liu, Fengrui Song, Zhiqiang Liu.  (2022)  Combined 16S rRNA gene sequencing and metabolomics to investigate the protective effects of Wu-tou decoction on rheumatoid arthritis in rats.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,      [PMID:35447521] [10.1016/j.jchromb.2022.123249]
14. Fangfang Xu, Jun Wang, Pan Wang, Tao Hou, Han Zhou, Yaopeng Zhao, Jixia Wang, Yanfang Liu, Xinmiao Liang.  (2022)  Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling.  EUROPEAN JOURNAL OF PHARMACOLOGY,      [PMID:35033554] [10.1016/j.ejphar.2022.174760]
15. Peijie Wu, Ling Qiao, Han Yu, Hui Ming, Chao Liu, Wenjun Wu, Baixue Li.  (2021)  Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation.  Frontiers in Cell and Developmental Biology,      [PMID:34926449] [10.3389/fcell.2021.758632]
16. Ya-Wen Zhang, Ling-Lan Tu, Yi Zhang, Jie-Chao Pan, Gao-Li Zheng, Li-Na Yin.  (2021)  Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.  DRUG DELIVERY,      [PMID:34854788] [10.1080/10717544.2021.2008054]
17. Chuang Zhang, Suolin Li, Chi Sun, Lin Liu, Yanbin Fang, Xiaofeng Yang, Xingxin Pan, Ben Zhang.  (2021)  Vitexin ameliorates glycochenodeoxycholate-induced hepatocyte injury through SIRT6 and JAK2/STAT3 pathways.  Iranian Journal of Basic Medical Sciences,      [PMID:35432812] [10.22038/IJBMS.2021.59424.13196]
18. Xinyue Li, Yaqi Yao, Meiling Chen, Haoran Ding, Chenrui Liang, Ling Lv, Huan Zhao, Guanru Zhou, Zhanglong Luo, Yubo Li, Han Zhang.  (2021)  Comprehensive evaluation integrating omics strategy and machine learning algorithms for consistency of calculus bovis from different sources.  TALANTA,      [PMID:34736706] [10.1016/j.talanta.2021.122873]
19. Cui Xiping, He Qiyi, Yang Huiyi, Chen Yingshan, Shen Ding, Eremin Sergei A., Mu Yunping, Zhao Suqing.  (2021)  Development of enzyme-free single-step immunoassays for glycocholic acid based on palladium nanoparticle-mediated signal generation.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,  413  (23): (5733-5742).  [PMID:34476526] [10.1007/s00216-021-03548-5]
20. Qiyi He, Yanxiong Fang, Huiyi Yang, Ding Shen, Yingshan Chen, Yingying Zhong, Xiangguang Li, Sergei A. Eremin, Xiping Cui, Suqing Zhao.  (2021)  Enhanced performance of a surface plasmon resonance-based immunosensor for the detection of glycocholic acid.  Analytical Methods,  13  (16): (1919-1924).  [PMID:33913980] [10.1039/D1AY00357G]
21. Min Wen, Yubei Liu, Ruiying Chen, Ping He, Feihua Wu, Rui Li, Yining Lin.  (2021)  Geniposide suppresses liver injury in a mouse model of DDC-induced sclerosing cholangitis.  PHYTOTHERAPY RESEARCH,  35  (7): (3799-3811).  [PMID:33763888] [10.1002/ptr.7086]
22. Yufei Sun, Zhiqiang Liu, Zifeng Pi, Fengrui Song, Jianlin Wu, Shu Liu.  (2021)  Poria cocos could ameliorate cognitive dysfunction in APP/PS1 mice by restoring imbalance of Aβ production and clearance and gut microbiota dysbiosis.  PHYTOTHERAPY RESEARCH,  35  (5): (2678-2690).  [PMID:33432644] [10.1002/ptr.7014]
23. Xiaofen Zhang, Ziyao Yang, Ziyu Shi, Zijia Zhu, Cai Li, Zhicheng Du, Yiding Zhang, Zipeng Wang, Zhenrui Jiao, Xin Tian, Ji Zhang, Wenlong Zhai, Quancheng Kan.  (2020)  Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.  JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY,      [PMID:33130021] [10.1016/j.jsbmb.2020.105775]
24. Qiyi He, Huiyi Yang, Yingshan Chen, Ding Shen, Xiping Cui, Chunguo Zhang, Huanxin Xiao, Sergei A. Eremin, Yanxiong Fang, Suqing Zhao.  (2020)  Prussian blue nanoparticles with peroxidase-mimicking properties in a dual immunoassays for glycocholic acid.  JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,      [PMID:32416340] [10.1016/j.jpba.2020.113317]
25. Meijing Liu, Guohui Zhang, Shuangcheng Wu, Meng Song, Jueyu Wang, Weibin Cai, Suiqing Mi, Changhui Liu.  (2020)  Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:32205261] [10.1016/j.jep.2020.112776]
26. Meijing Liu, Changhui Liu, Hao Chen, Xiaotao Huang, Xiaohui Zeng, Juncheng Zhou, Suiqing Mi.  (2017)  Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.  EUROPEAN JOURNAL OF PHARMACOLOGY,      [PMID:28993159] [10.1016/j.ejphar.2017.10.003]
27. Zhuo-Wei SHEN, Meng-Yue LUO, Hai-Hong HU, Hui ZHOU, Hui-Di JIANG, Lu-Shan YU, Su ZENG.  (2016)  Screening and verifying potential NTCP inhibitors from herbal medicinal ingredients using the LLC-PK1 cell model stably expressing human NTCP.  Chinese Journal of Natural Medicines,      [PMID:27507206] [10.1016/S1875-5364(16)30065-6]
28. Xing Zhou, Yang Zhao, Siyu Chen, Songling Han, Xiaoqiu Xu, Jiawei Guo, Mengyu Liu, Ling Che, Xiaohui Li, Jianxiang Zhang.  (2016)  Self-Assembly of pH-Responsive Microspheres for Intestinal Delivery of Diverse Lipophilic Therapeutics.  BIOMACROMOLECULES,      [PMID:27398635] [10.1021/acs.biomac.6b00512]
29. Pan Chen, Jingjie Li, Xiaomei Fan, Hang Zeng, Rongrong Deng, Dongshun Li, Min Huang, Huichang Bi.  (2015)  Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.  EUROPEAN JOURNAL OF PHARMACOLOGY,      [PMID:26297978] [10.1016/j.ejphar.2015.08.029]
30. Huang Xiaomei, Cao Xuejun.  (2015)  Preparation of ursodeoxycholic acid from 7-ketone lithocholic acid by stereoselective electroreduction.  Bioresources and Bioprocessing,  (1): (1-9).  [PMID:] [10.1186/s40643-015-0058-4]
31. Ma Xiaolei, Cao Xuejun.  (2014)  Separation of ursodeoxycholic acid by silylation crystallization.  Bioresources and Bioprocessing,  (1): (1-8).  [PMID:] [10.1186/s40643-014-0005-9]
32. Yuan Xiangxi, Ma Xiaolei, Cao Xuejun.  (2014)  Preparation of ursodeoxycholic acid by direct electro-reduction of 7-ketolithocholic acid.  KOREAN JOURNAL OF CHEMICAL ENGINEERING,  31  (7): (1276-1280).  [PMID:] [10.1007/s11814-013-0245-y]
33. Shun Zhang, Ting Cai, Jing Lin, Jia-Juan Liu, Yong-Gang Zhao, Min-Yi Cao.  (2024)  Analysis of 15 bile acids in human plasma based on C18 functionalized magnetic organic polymer nanocomposite coupled with liquid chromatography-tandem mass spectrometry.  JOURNAL OF CHROMATOGRAPHY A,      [PMID:38704923] [10.1016/j.chroma.2024.464962]
34. Younan Ren, Ying Chen, Emily H. Tang, Yixin Hu, Bo Niu, Huaduan Liang, Chuchu Xi, Fang Zhao, Zhengyu Cao.  (2024)  Arbidol attenuates liver fibrosis and activation of hepatic stellate cells by blocking TGF-β1 signaling.  EUROPEAN JOURNAL OF PHARMACOLOGY,      [PMID:38325795] [10.1016/j.ejphar.2024.176367]
35. Guoying Zhang, Wenjing Jia, Liying Liu, Luya Wang, Jiyu Xu, Jihong Tao, Mingting Xu, Min Yue, Huiqin Luo, Ping Hai, Huilan Yue, Dejun Zhang, Xiaohui Zhao.  (2024)  Caffeoylquinic acids from Silphium perfoliatum L. show hepatoprotective effects on cholestatic mice by regulating enterohepatic circulation of bile acids.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:39357582] [10.1016/j.jep.2024.118870]
36. Zhiyuan Zhang, Guoqiang Guan, Zixuan Tang, Weimin Wan, Zhipeng Huang, Yuefeng Wang, Jianzhao Wu, Bo Li, Mingli Zhong, Kefeng Zhang, Lixian Nong, Ya Gao, Houkang Cao.  (2024)  Desmodium styracifolium (Osb.) Merr. extracts alleviate cholestatic liver disease by FXR pathway.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:39454708] [10.1016/j.jep.2024.118972]
37. Miao Zheng, Qi Su, Haoqing Wu, Chenggang Cai, Le Thanh Ninh, Haiying Cai.  (2024)  Elucidating Bile Acid Tolerance in Saccharomyces cerevisiae: Effects on Sterol Biosynthesis and Transport Protein Expression.  Foods,  13  (21): (3405).  [PMID:39517189] [10.3390/foods13213405]
38. Yuan Li, Shu-Fang Li, Lin Zhang, Ya-Ping Xue, Yu-Guo Zheng.  (2024)  Engineering of a hydroxysteroid dehydrogenase with simultaneous enhancement in activity and thermostability for efficient biosynthesis of ursodeoxycholic acid.  APPLIED AND ENVIRONMENTAL MICROBIOLOGY,  90  (9):   [PMID:39207158] [10.1128/aem.01237-24]
39. Xue Bai, Zhiguang Duan, Jianjun Deng, Zhuo Zhang, Rongzhan Fu, Chenhui Zhu, Daidi Fan.  (2024)  Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism.  Journal of Advanced Research,      [PMID:38969093] [10.1016/j.jare.2024.06.028]
40. Qian Fang, Xiaoying Hou, Limei Fan, Yufei Deng, Xiaoxuan Li, Hongyun Zhang, Haiping Wang, Zhengqi Fu, Binlian Sun, Xiji Shu, Hongzhi Du, Yuchen Liu.  (2025)  Gut microbiota derived DCA enhances FOLFOX efficacy via Ugt1a6b mediated enterohepatic circulation in colon cancer.  PHARMACOLOGICAL RESEARCH,      [PMID:39894186] [10.1016/j.phrs.2025.107636]
41. Guoqiang Guan, Houkang Cao, Zixuan Tang, Kefeng Zhang, Mingli Zhong, Rui Lv, Weimin Wan, Fengyue Guo, Yongwang Wang, Ya Gao.  (2024)  Mechanistic studies on the alleviation of ANIT-induced cholestatic liver injury by Polygala fallax Hemsl. polysaccharides.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:38574780] [10.1016/j.jep.2024.118108]
42. Yanru Liu, Hui Chen, Gongjun Yang, Fang Feng.  (2024)  Metabolomics and serum pharmacochemistry combined with network pharmacology uncover the potential effective ingredients and mechanisms of Yin-Chen-Si-Ni Decoction treating ANIT-induced cholestatic liver injury.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:39163894] [10.1016/j.jep.2024.118713]
43. Yilong Liu, Ruoqi Wang, Jinren Zhou, Qiang Lyu, Xiaoyong Zhao, Xiaochun Yang, Kunsong Chen, Zhiwei Gao, Xian Li.  (2025)  Myricetin alleviates high-fat diet-induced atherosclerosis in ApoE−/− mice by regulating bile acid metabolism involved in gut microbiota remodeling.  Food & Function,      [PMID:40059779] [10.1039/D5FO00374A]
44. Wen Ma, Mingxia Liu, Mengling Tu, Gang Wang, Jun Li, Fen Liu, Jian Yang, Xianjiang Li.  (2024)  Novel multi-layered MXene as laser desorption ionization mass spectrometry matrix for rapid detection of small biomolecules.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2024.157466]
45. Fengxiang Tang, Haodong Yu, Yanzong Huang, Xue Zhao, Zixuan Chen, Honglin Ma, Bi-Yuan Zheng, Mei-Rong Ke, Yongfan Zhang, Xingshu Li, Juyoung Yoon, Jian-Dong Huang.  (2024)  Phthalocyanine J-aggregate nanoparticles with enormous-redshifted and intense absorption: Potential structure-J-aggregation relationships and application in tumor-associated macrophages-targeted phototheranostics.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2024.154272]
46. Zixuan Tang, Mingli Zhong, Houkang Cao, Yongwang Wang, Guoqiang Guan, Gang Wang, Jianzhao Wu, Fei Han, Ya Gao, Kefeng Zhang.  (2024)  Polysaccharide of Dicliptera chinensis (L.) Juss. alleviated cholestatic liver disease by modulating the FXR pathway.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,      [PMID:39383897] [10.1016/j.ijbiomac.2024.136393]
47. Xiaoqiang Zhu, Xiaojuan Dai, Lijun Zhao, Jing Li, Yanhong Zhu, Wenjuan He, Xinlei Guan, Tao Wu, Li Liu, Hongping Song, Liang Lei.  (2024)  Quercetin activates energy expenditure to combat metabolic syndrome through modulating gut microbiota-bile acids crosstalk in mice.  Gut Microbes,      [PMID:39163273] [10.1080/19490976.2024.2390136]
48. Yu-Ke Cen, Lin Zhang, Meng-Ping Liu, Chao Xiang, Tao-Xu Lu, Ya-Ping Xue, Yu-Guo Zheng.  (2025)  Salt-driven dynamic folding of halophile-origin enzymes: Insights into evolution and protein exploitation.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,      [PMID:39894131] [10.1016/j.ijbiomac.2025.140527]
49. Zhenxiu Liu, Lin Chen, Mingyun Chen, Lang Linghu, Zhihua Liao, Min Chen, Guowei Wang.  (2024)  Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1.  PHYTOMEDICINE,      [PMID:38788394] [10.1016/j.phymed.2024.155759]
50. Chunlei Wei, Lingjiao Wu, Yuyi Wu, Chunyi Xu, Huiling Hu, Zhanguo Wang.  (2024)  Selection and evaluation of quality markers (Q-markers) of vladimiriae radix extract for cholestatic liver injury based on spectrum-effect relationship, pharmacokinetics, and molecular docking.  JOURNAL OF ETHNOPHARMACOLOGY,      [PMID:38588988] [10.1016/j.jep.2024.118151]
51. Jiaorong QU, Xiaoyong XUE, Zhixing WANG, Zhi MA, Kexin JIA, Fanghong LI, Yinhao ZHANG, Ruiyu WU, Fei ZHOU, Piwen ZHAO, Xiaojiaoyang LI.  (2024)  Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition.  Chinese Journal of Natural Medicines,      [PMID:38278557] [10.1016/S1875-5364(24)60560-1]
52. Wang Le, Qu Jiaorong, Li Jianan, Xue Xiaoyong, Qin Lingling, Li Yufei, Dou Yuanfeng, Mu Xiaohong, Li Xiaojiaoyang.  (2024)  Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells.  Chinese Medicine,  19  (1): (1-19).  [PMID:39741334] [10.1186/s13020-024-01038-1]
53. Lou Yunpeng, Shi Hongguang, Sha Ning, Li Feifei, Gu Xiaofeng, Lin Huiyan.  (2025)  Ursodeoxycholic acid protects against sepsis-induced acute kidney injury by activating Nrf2/HO-1 and inhibiting NF-κB pathway.  BMC Nephrology,  26  (1): (1-14).  [PMID:39885380] [10.1186/s12882-025-03977-9]
54. Dan Hu, Xiaoting Wu, Manman Hou, Pin Song, Qu Chen, Yingdong Ni.  (2025)  Maternal exposure to high level of ursodeoxycholic acid during pregnancy promotes hepatic lipid deposition in the offspring by reducing the methylation level of Fasn gene.  BIOCHEMICAL PHARMACOLOGY,      [PMID:40653023] [10.1016/j.bcp.2025.117156]
55. Ci Song, Xiaomin Zheng, Zhenru Zhou, Yundong Yu, Lei Zhang, Shan Li.  (2025)  Enhanced Regioselectivity and Catalytic Activity on C7Hydroxylation of Lithocholic Acid to Produce Ursodeoxycholic Acid by Monooxygenase CYP107D1 Based on Semi-Rational Design.  Biotechnology Journal,  20  (7): (e70070).  [PMID:40654266] [10.1002/biot.70070]
56. Pengchao Xie, Yan Peng, Liyan Qiu.  (2022)  Responsive oligochitosan nano-vesicles with ursodeoxycholic acid and exenatide for NAFLD synergistic therapy via SIRT1.  CARBOHYDRATE POLYMERS,      [PMID:35450649] [10.1016/j.carbpol.2022.119388]
57. Jun Lin, Qixing Nie, Jie Cheng, Ya-Ni Zhong, Tianyao Zhang, Xiuying Zhang, Xiaoyan Ge, Yong Ding, Canyang Niu, Yuhua Gao, Kai Wang, Mingxin Gao, Xuemei Wang, Weixuan Chen, Chuyu Yun, Chuan Ye, Jinkun Xu, Weike Shaoyong, Lijun Zhang, Pan Shang, Xi Luo, Zhiwei Zhang, Xin Zheng, Xueying Sha, Jinxin Zhang, Shaoping Nie, Xuguang Zhang, Fazheng Ren, Huiying Liu, Erdan Dong, Xiao Yu, Linong Ji, Yanli Pang, Jin-Peng Sun, Changtao Jiang.  (2025)  A microbial amino-acid-conjugated bile acid, tryptophan-cholic acid, improves glucose homeostasis via the orphan receptor MRGPRE.  CELL,      [PMID:40446798] [10.1016/j.cell.2025.05.010]
58. Shuai Xue, Jianli Yin, Jiawei Shao, Yuanhuan Yu, Linfeng Yang, Yidan Wang, Mingqi Xie, Martin Fussenegger, Haifeng Ye.  (2017)  A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.  MOLECULAR THERAPY,      [PMID:28153094] [10.1016/j.ymthe.2016.11.008]
59. Yuan Li, Shu-Fang Li, Sen-Yu Fu, Xin-Ding Ren, Yi-Cheng Zhou, Ya-Ping Xue, Yu-Guo Zheng.  (2025)  Design of a Distal Site Saturation Test-Iterative Parallel Mutagenesis for Engineering Hydroxysteroid Dehydrogenase.  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,      [PMID:40205835] [10.1021/acs.jafc.4c12812]
60. Jiaorong Qu, Jianan Li, Le Wang, Yufei Li, Yinqiang Zhang, Jingtao Li, Zixuan Huo, Junsong Han, Runping Liu, Guifang Fan, Yinhao Zhang, Xiaoyong Xue, Xiaojiaoyang Li.  (2025)  Disturbance of cytoskeleton induced by ligustilide promotes hepatic stellate cell senescence and ameliorates liver fibrosis.  Theranostics,  15  (16): (8049).  [PMID:40860128] [10.7150/thno.108869]
61. Weirui Ren, Chuang Zhang, Hanyan Wang, Hongzhao Song, Xuejuan Zhu, Zhijun Zhang, Suxian Zhao, Junmin Wang.  (2025)  Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis and experimental validation.  Frontiers in Pharmacology,      [PMID:41142241] [10.3389/fphar.2025.1674693]
62. Zhihui Li, Yanqiu Gu, Jianbo Yang, Shaozhan Wang, Shengnan Li, Panpan Chen, Ru Yao, Fangbin Liu, Ying Wang, Rong Wang, Yongfang Yuan.  (2025)  Emodin and physcion alleviate cholestatic liver injury by targeting FXR: hepatoprotective components identified in processed Polygonum multiflorum Thunb. using a comprehensive two-dimensional biochromatography system.  Frontiers in Pharmacology,      [PMID:41487497] [10.3389/fphar.2025.1706401]
63. Jieying Zhou, Wei Luo, Lingxin Zeng, Shihao Xu, Ruohan Wu, Jiaqi Lu, Ying Li, Wei Xiong.  (2026)  A Bubble-Driven Drug Delivery System Enhances Oral Absorption and Antipyretic Efficacy of Poorly Water-Soluble Andrographolide.  International Journal of Nanomedicine,      [PMID:] [10.2147/IJN.S574265]
64. Hongyu Jiang, Wenyan Xiong, Yingna Feng, Xingjie Li, Jinzhuo Tan, Zongde Zhang.  (2026)  Bile acids enrichment fuel tumor aerobic glycolysis and immune evasion via stabilizing FXR-RARα.  Frontiers in Immunology,      [PMID:] [10.3389/fimmu.2026.1750358]
65. Danhua Zhu, Qingmiao Shi, Xiaoxi Ouyang, Yanhong Zhang, Xiaopeng Yu, Long Yang, Kunkai Su, Lanjuan Li.  (2026)  Integrative transcriptomic and metabolomic analyses of puerarin against cholestatic liver fibrosis.  Current Molecular Pharmacology,      [PMID:] [10.1016/j.cmp.2026.04.003]
Solution Calculators
Reviews

Customer Reviews

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.